Linzess (Linaclotide) For IBS With Constipation Or Chronic Idiopathic Constipation Now Available, USA27 Dec 2012-nbsp;-nbsp;-nbsp;
Linzess (linaclotide), a medication for irritable bowel syndrome (IBS) with constipation or chronic idiopathic constipation is now available in American pharmacies, Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc announced.
The FDA (Food and Drug Administration) recently approved the once-daily oral capsule, Linzess, for adults of either sex who suffer from IBS-C (IBS with constipation) or CIC (chronic idiopathic constipation).
Linaclotide is the only FDA-approved GC-C (guanylate cyclase-C) agonist that acts locally in the gut. Ironwood Pharmaceuticals says this is the first new prescription option for adults with these disorders in over six years.
About Linzess (linaclotide)
Linzess (linaclotide) is the "first and only guanylate cyclase
Hiç yorum yok:
Yorum Gönder